US Broker Ratings

Janux Therapeutics, Inc. (JANX) Stock Analysis: A Biotech Gamble with 142% Potential Upside

Janux Therapeutics, Inc. (NASDAQ: JANX) is making waves in the biotechnology sector, offering investors a tantalizing opportunity with a potential upside of over 142%. This clinical-stage..

Mesoblast Limited (MESO) Stock Analysis: Exploring a 141.88% Potential Upside for Biotech Investors

Mesoblast Limited (MESO), an Australian biotechnology firm, is stirring interest among investors with its promising pipeline and substantial potential upside. With a market capitalization of $1.88..

Denali Therapeutics Inc. (DNLI) Stock Analysis: Investors Eye 48% Potential Upside Amid Strong Buy Ratings

Denali Therapeutics Inc. (NASDAQ: DNLI), a biopharmaceutical leader specializing in neurodegenerative and lysosomal storage diseases, stands out in the biotechnology sector with a market cap of..

LeMaitre Vascular, Inc. (LMAT) Stock Analysis: Exploring a 14.61% Potential Upside in the Healthcare Sector

LeMaitre Vascular, Inc. (NASDAQ: LMAT), headquartered in Burlington, Massachusetts, stands as a noteworthy player in the healthcare sector, particularly within the medical instruments and supplies industry...

Structure Therapeutics Inc. (GPCR) Stock Analysis: Potential Upside of 116.78% Amid Promising Clinical Trials

Structure Therapeutics Inc. (NASDAQ: GPCR) is a name that has been increasingly capturing investor attention, and for good reason. With its market capitalization hitting $3.44 billion,..

Kestra Medical Technologies (KMTS) Stock Analysis: A 25% Upside Potential in the Medical Device Sector

Kestra Medical Technologies, Ltd. (NASDAQ: KMTS), a pioneering player in the medical instruments and supplies sector, is increasingly capturing investor attention with its innovative solutions in..

QuidelOrtho Corporation (QDEL) Stock Analysis: 20.46% Potential Upside Amidst Market Volatility

QuidelOrtho Corporation (NASDAQ: QDEL) stands as a prominent player in the healthcare sector, specifically within the medical devices industry. Headquartered in San Diego, California, the company..

CRISPR Therapeutics AG (CRSP) Stock Analysis: Exploring the 75% Potential Upside for Investors

CRISPR Therapeutics AG (NASDAQ: CRSP), a pioneering gene-editing biotechnology firm based in Switzerland, continues to capture the attention of investors with its groundbreaking CRISPR/Cas9 technology. With..

Ascentage Pharma Group Internat (AAPG) Stock Analysis: A Biotech Powerhouse with a Potential Upside of 182.98%

Ascentage Pharma Group International (AAPG), a clinical-stage biotechnology company based in Suzhou, China, is making waves in the healthcare sector. Specializing in developing cutting-edge therapies for..

NewAmsterdam Pharma (NAMS) Stock Analysis: Exploring an 86.77% Upside Potential

NewAmsterdam Pharma Company N.V. (NASDAQ: NAMS), a pioneering name in the biotechnology sector, is capturing investor attention with its promising pipeline and substantial upside potential. Based..

Guardian Pharmacy Services, Inc (GRDN) Stock Analysis: Exploring a 15.17% Upside Potential

Guardian Pharmacy Services, Inc. (NASDAQ: GRDN) is making waves in the healthcare sector, specifically within the medical care facilities industry. With its strategic focus on providing..

Dyne Therapeutics, Inc. (DYN) Stock Analysis: Exploring a 56% Potential Upside for Biotech Investors

Dyne Therapeutics, Inc. (NASDAQ: DYN), a leading player in the biotechnology sector, is gaining traction among investors with its promising pipeline of therapeutics targeting neuromuscular diseases...

Brookdale Senior Living Inc. (BKD)

⚠️ No article content returned.

..

Veracyte, Inc. (VCYT): Investor Outlook Reveals a 31.35% Potential Upside Amid Strong Analyst Ratings

Veracyte, Inc. (NASDAQ: VCYT) stands out in the healthcare sector, particularly within the diagnostics and research industry, as a company worth watching closely. With a robust..

Surgery Partners, Inc. (SGRY) Stock Analysis: Exploring a 16.04% Potential Upside for Healthcare Investors

Surgery Partners, Inc. (NASDAQ: SGRY), a key player in the healthcare sector, specializes in owning and operating a diverse network of surgical facilities across the United..

Disc Medicine, Inc. (IRON) Stock Analysis: Exploring a 32% Potential Upside with Strong Buy Ratings

Disc Medicine, Inc. (NASDAQ: IRON), a clinical-stage biopharmaceutical company, is garnering significant attention from investors with its promising therapeutic pipeline and potential for substantial stock upside...

Kymera Therapeutics, Inc. (KYMR) Stock Analysis: Exploring a Potential 26.79% Upside in the Biotech Frontier

Kymera Therapeutics, Inc. (NASDAQ: KYMR) has emerged as a notable player in the biotechnology sector, focusing on the next frontier of disease treatment through protein degradation...

Warby Parker Inc. (WRBY) Stock Analysis: Unpacking the 6.63% Potential Upside

Warby Parker Inc. (NYSE: WRBY) has carved a distinct niche in the healthcare sector, specifically within the medical instruments and supplies industry. The company, known for..

Apogee Therapeutics, Inc. (APGE) Stock Analysis: Navigating the Biotech Landscape with a $10 Billion Market Cap

Apogee Therapeutics, Inc. (NASDAQ: APGE), a notable player in the biotechnology sector, has been garnering attention from investors due to its significant market capitalization of $10.08..

ARS Pharmaceuticals, Inc. (SPRY) Investor Outlook: A 389.93% Potential Upside in Biotechnology

For investors keen on the biotechnology sector, ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) presents a compelling opportunity. With its focus on innovative treatments for severe allergic reactions..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds